Radwan El‐Haggar

850 citations

28 papers · 695 indexed · h-index 14

Organic Chemistry top 5%
- Synthesis and biological activity 16
- Synthesis and Characterization of Heterocyclic Compounds 6
- Quinazolinone synthesis and applications 6
- Click Chemistry and Applications 5
- Synthesis and Reactions of Organic Compounds 4
Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 3
Pharmacology top 10%
Molecular Biology
- Cancer therapeutics and mechanisms 5
- Enzyme function and inhibition 4
Pharmaceutical Science top 10%

Co-authors: Wagdy M. Eldehna Marwa F. Ahmed Hatem A. Abdel‐Aziz Eman Y. Santali Sara T. Al‐Rashood Mahmoud F. Abo-Ashour Alessandro Bonardi Claudiu T. Supuran
Cited by: Organic Chemistry Toxicology Pharmacology
Journals: Molecules (1 paper)European Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (1 paper)
Partner nations: Egypt Saudi Arabia France

In The Last Decade

Radwan El‐Haggar

26 papers receiving 689 citations

Peers

Countries citing papers authored by Radwan El‐Haggar

Since Specialization

Citations

This map shows the geographic impact of Radwan El‐Haggar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radwan El‐Haggar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radwan El‐Haggar more than expected).

Fields of papers citing papers by Radwan El‐Haggar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radwan El‐Haggar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radwan El‐Haggar. The network helps show where Radwan El‐Haggar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Radwan El‐Haggar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Radwan El‐Haggar Line = papers co-authored together Radwan El‐Haggar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Novel and sustainable microfabricated Cu ion selective sensor doped with ionophore and supported with docking study for determination of vonoprazan fumarate in tablet dosage form BMC Chemistry ·Helal Zaher,Emad Ramzy,Amr M. Mahmoud,Mona S. Elshahed,Radwan El‐Haggar	2026	0
2	Amino acid–modified chalcone derivatives with in vitro and in vivo efficacy against colon cancer European Journal of Medicinal Chemistry ·Radwan El‐Haggar,Reem I. Alsantali,Ahmed M Aboshanab,Mahmoud Abdelrahman Alkabbani,Yara E. Mansour,Samar S. Fatahala,Nicolas Masurier	2025	1
3	An overview of synthetic approaches and the potential bioactivity of different 1,2,3-triazole hybrids Egyptian Pharmaceutical Journal ·Wafaa A. Zaghary,Manal M. Anwar,Radwan El‐Haggar,Yasmin M. Syam,Alaa H. Hashim	2024	1
4	2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling European Journal of Medicinal Chemistry ·Moataz A. Shaldam,Denisa Hendrychová,Radwan El‐Haggar,Veronika Vojáčková,Taghreed A. Majrashi,Eslam B. Elkaeed,Nicolas Masurier,Vladimı́r Kryštof,Haytham O. Tawfik,Wagdy M. Eldehna	2023	19
5	New phenothiazine conjugates as apoptosis inducing agents: Design, synthesis, In-vitro anti-cancer screening and 131I-radiolabeling for in-vivo evaluation Bioorganic Chemistry ·Mona O. Sarhan,Hesham Haffez,Nosaiba A. Elsayed,Radwan El‐Haggar,Wafaa A. Zaghary	2023	4
6	Novel N -Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations Journal of Enzyme Inhibition and Medicinal Chemistry ·Hesham Haffez,Nosaiba A. Elsayed,Marwa F. Ahmed,Samar S. Fatahala,Eman F. Khaleel,Rehab Mustafa Badi,Eslam B. Elkaeed,Mahmoud A. El Hassab,Sherif Hammad,Wagdy M. Eldehna,Nicolas Masurier,Radwan El‐Haggar	2023	3
7	In Silico ADME Prediction and Molecular Docking of 1,2,3-Triazole-based Compounds Against Human Aromatase Cytochrome P450 Ola Nosseir,Yasmin M. Syam,Alaa Hashim,Radwan El‐Haggar,Manal M. Anwar,Wafaa A. Zaghary	2023	1
8	Novel hydrazone‐isatin derivatives as potential EGFR inhibitors: Synthesis and in vitro pharmacological profiling Archiv der Pharmazie ·Marwa F. Ahmed,Radwan El‐Haggar,Atiah H. Almalki,Omeima Abdullah,Mahmoud A. El Hassab,Nicolas Masurier,Sherif Hammad	2023	22
9	Synthesis of new 1,2,3-triazole-based compounds of potential anti-breast cancer activity targeting aromatase enzyme inhibition Egyptian Journal of Chemistry ·Yasmin M. Syam,Radwan El‐Haggar,Manal M. Anwar,Alaa Hashim,Ola Nosseir,Wafaa A. Zaghary	2023	0
10	Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates via a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers Journal of Enzyme Inhibition and Medicinal Chemistry ·Ibrahim H. Eissa,Radwan El‐Haggar,Mohammed A. Dahab,Marwa F. Ahmed,Hazem A. Mahdy,Reem I. Alsantali,Alaa Elwan,Nicolas Masurier,Samar S. Fatahala	2022	17
11	3-Substituted-2,3-Dihydrothiazole as a promising scaffold to design EGFR inhibitors Bioorganic Chemistry ·Radwan El‐Haggar,Sherif Hammad,Reem I. Alsantali,Munira M. Alrooqi,Mahmoud A. El Hassab,Nicolas Masurier,Marwa F. Ahmed	2022	7
12	Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations Bioorganic Chemistry ·Wagdy M. Eldehna,Mahmoud A. El Hassab,Mahmoud F. Abo-Ashour,Tarfah Al‐Warhi,Mahmoud M. Elaasser,Nesreen A. Safwat,Howayda Suliman,Marwa F. Ahmed,Sara T. Al‐Rashood,Hatem A. Abdel‐Aziz,Radwan El‐Haggar	2021	80
13	Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells European Journal of Medicinal Chemistry ·Andrea Petreni,Alessandro Bonardi,Carrie L. Lomelino,Sameh M. Osman,Zeid A. ALOthman,Wagdy M. Eldehna,Radwan El‐Haggar,Robert McKenna,Alessio Nocentini,Claudiu T. Supuran	2020	60
14	Development of pyridazine derivatives as potential EGFR inhibitors and apoptosis inducers: Design, synthesis, anticancer evaluation, and molecular modeling studies Bioorganic Chemistry ·Marwa F. Ahmed,Eman Y. Santali,Eman M. Mohi El-Deen,Ibrahim A. Naguib,Radwan El‐Haggar	2020	26
15	3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies European Journal of Medicinal Chemistry ·Abdulsalam A. M. Alkhaldi,Mohammad M. Al‐Sanea,Alessio Nocentini,Wagdy M. Eldehna,Zainab M. Elsayed,Alessandro Bonardi,Mahmoud F. Abo-Ashour,Ashraf K. El‐Damasy,Mohammed S. Abdel‐Maksoud,Tarfah Al‐Warhi,Paola Gratteri,Hatem A. Abdel‐Aziz,Claudiu T. Supuran,Radwan El‐Haggar	2020	62
16	Introducing of potent cytotoxic novel 2-(aroylamino)cinnamamide derivatives against colon cancer mediated by dual apoptotic signal activation and oxidative stress Bioorganic Chemistry ·Abdelsattar M. Omar,Moustafa E. El‐Araby,Tamer M. Abdelghany,Martin K. Safo,Mostafa H. Ahmed,Rio S. Boothello,Bhaumik B. Patel,Mohamed S. Abdel‐Bakky,Azizah M. Malebari,Hany E. A. Ahmed,Radwan El‐Haggar	2020	4
17	Development of 2-oxindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells Journal of Enzyme Inhibition and Medicinal Chemistry ·Wagdy M. Eldehna,Mahmoud F. Abo-Ashour,Tarfah Al‐Warhi,Sara T. Al‐Rashood,Amal Alharbi,Rezk R. Ayyad,Khayal Al‐Khayal,Maha Abdulla,Hatem A. Abdel‐Aziz,Rehan Ahmad,Radwan El‐Haggar	2020	20
18	Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents European Journal of Medicinal Chemistry ·Wagdy M. Eldehna,Mahmoud F. Abo-Ashour,Alessio Nocentini,Radwan El‐Haggar,Silvia Bua,Alessandro Bonardi,Sara T. Al‐Rashood,Ghada S. Hassan,Paola Gratteri,Hatem A. Abdel‐Aziz,Claudiu T. Supuran	2018	86
19	Salmeterol Xinafoate PubMed ·Manal M. Anwar,Radwan El‐Haggar,Wafaa A. Zaghary	2015	8
20	Synthesis, evaluation and molecular docking studies for the anti-inflammatory activity of novel 8-substituted- 7-benzoyloxy-4-methyl-6-nitrocoumarin derivatives African Journal of Pharmacy and Pharmacology ·Radwan El‐Haggar,Ola Ahmed Abdel-Rasheed,Tamer Nasr,Hamed I. Ali,A. Goudah,Nageh Abotaleb	2014	3

About Radwan El‐Haggar

Radwan El‐Haggar is a scholar working on Toxicology, Organic Chemistry and Molecular Biology, having authored 28 papers that have together received 695 indexed citations. Recurring topics across this work include Synthesis and biological activity (16 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers), Quinazolinone synthesis and applications (6 papers), Click Chemistry and Applications (5 papers), Cancer therapeutics and mechanisms (5 papers), Enzyme function and inhibition (4 papers), Synthesis and Reactions of Organic Compounds (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Organic Chemistry (505 citations), Toxicology (41 citations) and Pharmacology (96 citations). Radwan El‐Haggar has collaborated with scholars based in Egypt, Saudi Arabia and France. Frequent co-authors include Wagdy M. Eldehna, Marwa F. Ahmed, Hatem A. Abdel‐Aziz, Eman Y. Santali, Sara T. Al‐Rashood, Mahmoud F. Abo-Ashour, Alessandro Bonardi, Claudiu T. Supuran, Alessio Nocentini and Mahmoud A. El Hassab. Their work appears in journals such as Molecules, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact